Evidence map›Paper›PMID 31746534›Full record

ArticleAddiction biology2020

Subcortical surface morphometry in substance dependence: An ENIGMA addiction working group study.

Yann Chye, Scott Mackey, Boris A Gutman, Christopher R K Ching, Albert Batalla, Sara Blaine, Samantha Brooks, Elisabeth C Caparelli, Janna Cousijn, Alain Dagher and 34 more

Open access · bronzeAbstract read
In one paragraph

Article in Addiction biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 5 pooled it
6.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 5 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. A 3D Brain Geometry Toolkit for Multisite Neuroimaging Analysis.bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

44 authors at 20 institutions in 8 countries.

Yann ChyeTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria, Australia.ORCID 0000-0001-9470-4241
Scott MackeyDepartments of Psychiatry, University of Vermont, Burlington, VT, USA.
Boris A GutmanBiomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA.
Christopher R K ChingDepartment of Neurology, Keck School of Medicine, Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, CA, USA.
Albert BatallaDepartment of Psychiatry, University Medical Centre Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.ORCID 0000-0002-5010-5121
Sara BlaineDepartments of Psychiatry and Neuroscience, Yale University School of Medicine, CT, USA.
Samantha BrooksFaculty of Health, School of Psychology, Liverpool John Moores University, L3 3AF, Liverpool UK.ORCID 0000-0002-9146-6257
Elisabeth C CaparelliNeuroimaging Research Branch, Intramural Research Program, National Institute of Drug Abuse, Baltimore, MD, USA.
Janna CousijnDepartment of Developmental Psychology, University of Amsterdam, The Netherlands.
Alain DagherMcConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.ORCID 0000-0002-0945-5779
John J FoxeDepartment of Neuroscience & The Ernest J. Del Monte Institute for Neuroscience, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.ORCID 0000-0002-4300-3098
Anna E GoudriaanAmsterdam UMC, Department of Psychiatry, Amsterdam Institute for Addiction Research, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-8670-9384
Robert HesterMelbourne School of Psychological Sciences, University of Melbourne, Melbourne, Victoria, Australia.
Kent HutchisonDepartment of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO, USA.
Neda JahanshadDepartment of Neurology, Keck School of Medicine, Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, CA, USA.
Anne M KaagDepartment of Developmental Psychology, University of Amsterdam, The Netherlands.ORCID 0000-0001-5696-5758
Ozlem KorucuogluDepartment of Psychiatry, Washington University School of Medicine, Saint Louis, MO, USA.
Chiang-Shan R LiDepartments of Psychiatry and Neuroscience, Yale University School of Medicine, CT, USA.ORCID 0000-0002-9393-1212
Edythe D LondonJane and Terry Semel Institute of Neuroscience and Human Behavior, David Geffen School of Medicine, Universityof California at Los Angeles, Los Angeles, CA, USA.ORCID 0000-0003-3577-7808
Valentina LorenzettiTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria, Australia.
Maartje LuijtenBehavioural Science Institute, Radboud University, Nijmegen, The Netherlands.ORCID 0000-0003-4158-4391
Rocio Martin-SantosDepartment of Psychiatry and Psychology, Hospital Clinic, IDIBAPS, CIBERSAM, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.ORCID 0000-0003-4150-4726
Shashwath A MedaOlin Neuropsychiatry Research Center, Hartford Hospital/IOL, Hartford, CT, USA.
Reza MomenanClinical NeuroImaging Research Core, Division of Intramural Clinical and BiologicalResearch, National Institute of Alcohol Abuse and Alcoholism, Bethesda, MD, USA.
Angelica MoralesJane and Terry Semel Institute of Neuroscience and Human Behavior, David Geffen School of Medicine, Universityof California at Los Angeles, Los Angeles, CA, USA.
Catherine OrrDepartments of Psychiatry, University of Vermont, Burlington, VT, USA.ORCID 0000-0001-7042-8748
Martin P PaulusVA San Diego Healthcare System and Department of Psychiatry, University of California San Diego, CA, USA.
Godfrey PearlsonDepartments of Psychiatry and Neuroscience, Yale University School of Medicine, CT, USA.
Liesbeth RenemanDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, location AMC, Amsterdam, The Netherlands.
Lianne SchmaalOrygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia.
Rajita SinhaDepartments of Psychiatry and Neuroscience, Yale University School of Medicine, CT, USA.
Nadia SolowijSchool of Psychology and Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, New South Wales, Australia.ORCID 0000-0002-5222-5637
Dan J SteinSA MRC Unit on Risk & Resilience in Mental Disorders, Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
Elliot A SteinNeuroimaging Research Branch, Intramural Research Program, National Institute of Drug Abuse, Baltimore, MD, USA.
Deborah TangMcConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
Anne UhlmannDepartment of Psychiatry and Mental Health, Faculty of Health Sciences University of Cape Town, South Africa.
Ruth van HolstDepartment of Psychiatry, University of Amsterdam, Amsterdam, The Netherlands.
Dick J VeltmanDepartment of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands.
Antonio Verdejo-GarciaTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria, Australia.ORCID 0000-0001-8874-9339
Reinout W WiersAddiction Development and Psychopathology (ADAPT) Lab, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-4312-9766
Murat YücelTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria, Australia.
Paul M ThompsonDepartment of Neurology, Keck School of Medicine, Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, CA, USA.
Patricia ConrodDepartment of Psychiatry, Université de Montreal, CHU Ste Justine Hospital, Canada.
Hugh GaravanDepartments of Psychiatry, University of Vermont, Burlington, VT, USA.
Monash University · AUYale University · USUniversity of Southern California · USUniversity of Vermont · USAmsterdam Institute for Addiction Research · NLMontreal Neurological Institute and Hospital · CANational Institute on Drug Abuse · USThe University of Melbourne · AUUniversity of Amsterdam · NLUniversity of California, Los Angeles · USUniversity of Cape Town · ZAAmsterdam Neuroscience · NLAmsterdam UMC Location Vrije Universiteit Amsterdam · NLAmsterdam University of Applied Sciences · NLCentre Hospitalier Universitaire Sainte-Justine · CACentro de Investigación Biomédica en Red de Salud Mental · ESHartford Hospital · USIllinois Institute of Technology · USNational Institute on Alcohol Abuse and Alcoholism · USRadboud University Nijmegen · NL

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
ZDV &3TC NEVIRAPINE COMBINATION THERAPY IN HIV 1 INFECTED INFANTS &M01RR000865 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WASHINGTON, ARNOLD E. · 1985 to 2011
$43.4M
Brain Imaging of Human Drug AbuseZIADA000470 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI STEIN, ELLIOT A · 2009 to 2021
$15.8M
Chronic Alcohol and Brain Stress Circuit ResponseR01AA013892 · NIAAA · YALE UNIVERSITY · PI Rajita Sinha · 2003 to 2026
$10.1M
Training U54EB020403 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2014 to 2018
$10.1M
Functional & Structural Connectivity of Alcohol Use DisordersZIAAA000123 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI MOMENAN, REZA · 2015 to 2022
$7.8M
UCLA Training Program in Translational Neuroscience of Drug Abuse (TNDA)T32DA024635 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LARA A. RAY, Kate M Wassum · 2008 to 2026
$6.2M
ENIGMA- Addiction: Pooling of Existing Datasets to Identify Brain and Genetic Correlates of Addiction, Next StepsR01DA047119 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HUGH P. GARAVAN · 2018 to 2026
$5.4M
Cognitive control and cocaine dependence: thalamic noradrenergic processesR01DA023248 · NIDA · YALE UNIVERSITY · PI LI, CHIANG-SHAN RAY · 2008 to 2018
$4.0M
Protocols, Statistics, Collaborative Method Development and ToolsPL1DA024859 · NIDA · YALE UNIVERSITY · PI SINHA, RAJITA · 2007 to 2011
$3.6M
RESEARCH TRAINING: PSYCHOBIOLOGICAL SCIENCEST32MH017140 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LEUCHTER, ANDREW F · 1985 to 2012
$3.2M
Alcohol Use in College Students:Cognition and fMRIR01AA016599 · NIAAA · YALE UNIVERSITY · PI PEARLSON, GODFREY D · 2008 to 2012
$3.0M
CIHRIntramural NIH HHS ZIA AA000123NCATS NIH HHS UL1 TR001863NCRR NIH HHS M01 RR000865NCRR NIH HHS UL1 RR024925NIAAA NIH HHS L30 AA024302NIAAA NIH HHS R00 AA025401NIAAA NIH HHS R01 AA013892NIAAA NIH HHS R01 AA016599NIAAA NIH HHS R01 AA021449NIAAA NIH HHS RC1 AA019036NIA NIH HHS T32 AG058507NIBIB NIH HHS U54 EB020403NIDA NIH HHS F30 DA021961NIDA NIH HHS K25 DA040032NIDA NIH HHS P20 DA022539NIDA NIH HHS PL1 DA024859NIDA NIH HHS R01 DA014100NIDA NIH HHS R01 DA015179NIDA NIH HHS R01 DA018307NIDA NIH HHS R01 DA020709NIDA NIH HHS R01 DA023248NIDA NIH HHS R01 DA047119NIDA NIH HHS RL1 DA024853NIDA NIH HHS T32 DA024635NIMH NIH HHS R01 MH116147NIMH NIH HHS T32 MH017140NIMH NIH HHS T32 MH073526
6 · The paper itself

Abstract

While imaging studies have demonstrated volumetric differences in subcortical structures associated with dependence on various abused substances, findings to date have not been wholly consistent. Moreover, most studies have not compared brain morphology across those dependent on different substances of abuse to identify substance-specific and substance-general dependence effects. By pooling large multinational datasets from 33 imaging sites, this study examined subcortical surface morphology in 1628 nondependent controls and 2277 individuals with dependence on alcohol, nicotine, cocaine, methamphetamine, and/or cannabis. Subcortical structures were defined by FreeSurfer segmentation and converted to a mesh surface to extract two vertex-level metrics-the radial distance (RD) of the structure surface from a medial curve and the log of the Jacobian determinant (JD)-that, respectively, describe local thickness and surface area dilation/contraction. Mega-analyses were performed on measures of RD and JD to test for the main effect of substance dependence, controlling for age, sex, intracranial volume, and imaging site. Widespread differences between dependent users and nondependent controls were found across subcortical structures, driven primarily by users dependent on alcohol. Alcohol dependence was associated with localized lower RD and JD across most structures, with the strongest effects in the hippocampus, thalamus, putamen, and amygdala. Meanwhile, nicotine use was associated with greater RD and JD relative to nonsmokers in multiple regions, with the strongest effects in the bilateral hippocampus and right nucleus accumbens. By demonstrating subcortical morphological differences unique to alcohol and nicotine use, rather than dependence across all substances, results suggest substance-specific relationships with subcortical brain structures.

Indexed as

NeuroimagingAdolescentAdultBrainCannabisCocaineEthanolFemaleHumansMagnetic Resonance ImagingMaleMethamphetamineNicotineSubstance-Related DisordersYoung AdultCocaineEthanolMethamphetamineNicotineaddictionstructural MRIsubstance dependence

Identifiers

PMID31746534
PMCPMC7237314
OpenAlexW2990152778

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.